商业化
中国
苏云金杆菌
生物技术
政府(语言学)
基因工程
转基因作物
业务
人类健康
农业经济学
生物
政治学
经济
转基因
基因
营销
法学
医学
语言学
哲学
生物化学
环境卫生
细菌
遗传学
作者
Yunhe Li,Eric M. Hallerman,Yufa Peng
标识
DOI:10.1016/j.tifs.2018.01.012
摘要
Recent documents issued by the State Council of China indicate that China's central government is paving the way to commercial cultivation of genetically engineered (GE) staple crops, with priority on insect-resistant GE (IRGE) maize expressing Bacillus thuringiensis (Bt) proteins. Multiple Bt maize lines have been developed in China, and their efficacy and benefits to human health and the environment have been demonstrated. We here consider issues regarding approval of GE lines for international trade, measures to be taken to ensure harmonious co-production of GE and non-GE crops, and management of evolution of Bt resistance in maize pests that should be addressed before commercialization of Bt maize in China.
科研通智能强力驱动
Strongly Powered by AbleSci AI